JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB11862

Anti-C3 antibody [11H9]

4

(4 Reviews)

|

(107 Publications)

Anti-C3 antibody [11H9] (ab11862) is a rat monoclonal antibody detecting C3/C3b in ICC/IF. Suitable for Mouse.

- Over 50 publications
- Trusted since 2004

View Alternative Names

Complement C3, HSE-MSF, C3

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-C3 antibody [11H9] (AB11862)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-C3 antibody [11H9] (AB11862)

ab11862 staining C3 in murine kidney cells by Immunocytochemistry/ Immunofluorescence.C3 protein fragments deposited on kidney cells of MPL-lpr mouse. Glomerular staining pattern.

Western blot - Anti-C3 antibody [11H9] (AB11862)
  • WB

CiteAb

Western blot - Anti-C3 antibody [11H9] (AB11862)

Western Blotting using Anti-C3 antibody [11H9], ab11862. Publication image from Zhang, B. et al., 2017, Acta Neuropathol, 28612290. Legend direct from paper.

A decrease in TYROBP protein decreases oligomeric Aβ levels and alters phospho-TAU, synaptophysin, LAMP1, and complement C3 levels in 4-month-old APP/PSEN1 mice. a–c Hemibrains of male and female APP/PSEN1 (n = 4–6), APP/PSEN1; Tyrobp+/− (n = 3–8) and APP/PSEN1; Tyrobp−/− (n = 3–4) mice were processed via differential detergent solubilization to produce fractions of TBS soluble, Triton-X soluble, and formic acid soluble Aβ. Oligomeric Aβ was assessed from the TBS-soluble fraction via dot blot analyses using NU-4 (a), A11 (b) and OC (c) antibodies. d–i Western blot analysis in brain protein homogenates from 4-month-old male and female mice WT, Tyrobp+/−, Tyrobp−/− and APP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. d, e Phospho-tau (AT8 epitope)/total tau ratio for dWT, Tyrobp+/−, Tyrobp−/− mice and eAPP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. f, g Synaptophysin level for fWT, Tyrobp+/−, Tyrobp−/− mice and gAPP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. h Marker of dystrophic neurites (Lamp1) in APP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. i Complement C3 in APP/PSEN1, APP/PSEN1; Tyrobp+/− and APP/PSEN1; Tyrobp−/− mice. At least two independent western blot analyses were performed. Representative immunoreactive bands from the same western blot are shown on the right. n = 3–6 mice per group. Two-way ANOVA corrected for multiple comparisons (Tukey) was used for all statistical comparisons in male and female mice, *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001. Data presented as mean ± SEM

false

Key facts

Host species

Rat

Clonality

Monoclonal

Clone number

11H9

Isotype

IgG2a

Carrier free

No

Reacts with

Mouse

Applications

ICC/IF

applications

Immunogen

Cell preparation containing C3 protein. The exact immunogen used to generate this antibody is proprietary information.

P01027

Specificity

This antibody recognizes both intact C3 and its cleaved products C3b, iC3b, C3d and C3dg.The mature protein C3 has a molecular weight of approximately 190 kDa. The complement factor C3 consists of an alpha- and a beta-chain, linkedby disulfide bond. C3 convertase activates C3 by cleaving the alpha chain, releasing C3a anaphylotoxin and generating C3b (alpha chain and beta chain). C3b has a molecular weight of approximately 185 kDa. C3b is rapidly split in two positions by factor I and a cofactor to formiC3b (inactivated C3b) and C3f which is released. iC3b has a molecular weight of approximately 182 kDa. Does not cross react with C4.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-C3 antibody [11H9] (ab11862) is a rat monoclonal antibody and is validated for use in Immunocytochemistry/immunofluorescence (ICC/IF) in Mouse samples.

Trusted by the scientific community
Anti-C3 [11H9] (ab11862) was first used in a scientific publication in 2004 and has been cited over 50 times in peer-reviewed journals.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
0.2 µm filtered
Storage buffer
Preservative: 0.02% Sodium azide Constituents: PBS, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Complement component 3 (C3) commonly known as C3 complement is a central protein in the complement system which plays a significant role in immune response. C3b a fragment of C3 is produced when C3 undergoes cleavage. C3 is a large protein with a mass of approximately 185 kDa. The liver primarily secretes C3 into the bloodstream. It circulates in the plasma and is found in high concentration making it one of the most abundant components of the complement system.
Biological function summary

Complement component C3 forms part of the innate immune system by promoting opsonization which enhances phagocytosis of pathogens. C3b binds to pathogens' surfaces facilitating their recognition by phagocytes. C3 as part of a complex with C3 convertase also has a role in amplifying the activation of the complement cascade. The proteolytic cleavage of C3 into C3b and C3a leads to the activation of other components forming the membrane attack complex and orchestrating inflammation.

Pathways

The complement component C3 functions within both the classical and alternative complement pathways. It acts as a convergence point where the complement activation pathways meet. C3 is activated into C3b and C3a which are key to amplifying the cascade. Furthermore C3 interacts with proteins such as factor B and factor D in the alternative pathway and C4 and C2 in the classical pathway facilitating the formation of C3 convertase necessary for pathway progression.

Complement C3 shows associations with immune-related and inflammatory diseases. Deficiencies or malfunctions of complement C3 can lead to increased susceptibility to infections due to impaired opsonization and clearance of pathogens. Additionally overactivation of the complement system involving C3 can contribute to autoimmune disorders such as systemic lupus erythematosus. Other proteins linked to these diseases include C4 in lupus and factor H in age-related macular degeneration which controls complement pathway activation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Precursor of non-enzymatic components of the classical, alternative, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system.. Complement C3b. Non-enzymatic component of C5 convertase. Generated following cleavage by C3 convertase, it covalently attaches to the surface of pathogens, where it acts as an opsonin that marks the surface of antigens for removal. Complement C3b binds covalently via its reactive thioester, to cell surface carbohydrates or immune aggregates. Together with complement C4b, it then recruits the serine protease complement C2b to form the C5 convertase, which cleaves and activate C5, the next component of the complement pathways. In the alternative complement pathway, recruits the serine protease CFB to form the C5 convertase that cleaves and activates C5.. C3a anaphylatoxin. Mediator of local inflammatory process released following cleavage by C3 convertase. Acts by binding to its receptor, C3AR1, activating G protein-coupled receptor signaling, promoting the phosphorylation, ARRB2-mediated internalization and endocytosis of C3AR1. C3a anaphylatoxin stimulates the activation of immune cells such as mast cells and basophilic leukocytes to release inflammation agents, such as cytokines, chemokines and histamine, which promote inflammation development. Also acts as potent chemoattractant for the migration of macrophages and neutrophils to the inflamed tissues, resulting in neutralization of the inflammatory triggers by multiple ways, such as phagocytosis and generation of reactive oxidants.. Acylation stimulating protein. Adipogenic hormone that stimulates triglyceride synthesis and glucose transport in adipocytes, regulating fat storage and playing a role in postprandial triglyceride clearance. Appears to stimulate triglyceride synthesis via activation of the PLC, MAPK and AKT signaling pathways. Acts by binding to its receptor, C5AR2, activating G protein-coupled receptor signaling, promoting the phosphorylation, ARRB2-mediated internalization and endocytosis of C5AR2. In contrast to C3a anaphylatoxin peptide, does not show pro-inflammatory activity.. C3-beta-c. Acts as a chemoattractant for neutrophils in chronic inflammation.
See full target information C3

Publications (107)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 8:1446 PubMed41068254

2025

Cxcl9 macrophages recruit circulating Cxcr3+ plasmablasts into kidneys to promote pathogenesis of lupus nephritis mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Zhao,Xinlong Bai,Cheng Zhou,Qing Ouyang,Yingjie Zhang,Xiao Zhang,Xumin Zheng,Chaofan Li,Wanjun Shen,Qinggang Li,Guangyan Cai,Xiangmei Chen,Ping Li,Xue-Yuan Bai

Nature 647:498-505 PubMed40931063

2025

Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus.

Applications

Unspecified application

Species

Unspecified reactive species

Qintao Wang,Honghao Zhu,Xiangwei Sun,Changming Zhang,Shuangyue Ma,Ying Jin,Jinjian Fu,Chenlu Liu,Jiahui Peng,Ruoran Wang,Lin Liu,Yi Zeng,Cheng Gong,Qing Zhou,Xiaomin Yu,Zhihong Liu

Haematologica : PubMed40820810

2025

KLF4 overexpression protects against complement-mediated endothelial injury in transplant-associated thrombotic microangiopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Shuhui Jiang,Jiaqian Qi,Tingting Pan,Zhenzhen Yao,Siyi Lu,Yifei Han,Depei Wu,Yue Han

IBRO neuroscience reports 19:300-306 PubMed40747365

2025

Reactive astrocyte-derived neurotoxicity is mitigated by vitronectin in traumatic brain injury mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Minori Yamashita,Nito Nakahira,Kei Hashimoto,Hirono Kobayashi,Mari Nakashima,Hiroko Ikeshima-Kataoka,Yasunori Miyamoto

ACS omega 10:28446-28465 PubMed40657111

2025

Drug Repurposing by Virtual Screening: Identification of New Already Approved ROCK Inhibitors as Promising Drugs to Target Neurodegeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Lucas Silva Franco,Daniel Alencar Rodrigues,Gabriela Joras Baumart,Bárbara da Silva Mascarenhas de Jesus,Flávia Carvalho Alcantara Gomes,Lídia Moreira Lima,Carlos Alberto Manssour Fraga,Pedro de Sena Murteira Pinheiro

Cell death discovery 11:320 PubMed40651955

2025

Inhibition of VEGFR-3 by SAR131675 decreases renal inflammation and lymphangiogenesis in the murine lupus nephritis model.

Applications

Unspecified application

Species

Unspecified reactive species

Tian Wang,Wenjia Li,Ji-Hyun Yeom,Zhiheng Liu,Kyoung Min Kim,Kyung Pyo Kang

Journal of inflammation research 18:8579-8592 PubMed40620607

2025

Immune Cell Characteristics in a Gut-Kidney Axis-Induced Mouse Model of IgA Nephropathy: The Upregulated Dendritic Cells and Neutrophils.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaqi Liu,Yuna Chen,Qijun Wan

BMC microbiology 25:412 PubMed40615777

2025

FabG moonlights as an extracellular adhesin mediates cytoadhesion of Streptococcus suis via interaction with plasminogen.

Applications

Unspecified application

Species

Unspecified reactive species

Genglin Guo,Yu Zhou,Pei Li,Quan Li,Yanfei Yu,Wei Zhang

Journal of neuroinflammation 22:69 PubMed40055743

2025

Intravitreal delivery of NMO-IgG causes primary retinal damage in the absence of optic nerve injury.

Applications

Unspecified application

Species

Unspecified reactive species

Biyue Chen,Huanfen Zhou,Mingming Sun,Wanqun Yang,Qianqian Li,Kaishu Yang,Honglu Song,Quangang Xu,Xintong Xu,Yuyu Li,Yanyan Yu,Shihui Wei,Tingjun Chen

mSystems 10:e0154024 PubMed40008883

2025

Dual RNA-seq reveals the complement protein C3-mediated host-pathogen interaction in the brain abscess caused by .

Applications

Unspecified application

Species

Unspecified reactive species

Qiyuan Jin,Yaxuan Zhai,Rui Qiang,Xin Ma,Chenhao Zhao,Jinqi Zhong,Jijie Li,Qi Chen,Mingxiao Han,Hong Du,Qifei Cong,Haifang Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com